Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 55 (RPL23AP55)
- Target
- RPL23AP55
- Molecular classification
- Other (Pseudogene; non-coding RNA locus)
01
Overview
Ribosomal protein L23a pseudogene 55 (RPL23AP55) is a non-coding pseudogene in the human genome, derived from the RPL23A gene that encodes a ribosomal protein. This locus does not produce a functional protein and is considered a processed pseudogene. While the biological role of RPL23AP55 is not established, some ribosomal pseudogenes have been investigated for potential regulatory functions such as acting as competing endogenous RNAs ("molecular sponges") for microRNAs. There is currently no evidence that RPL23AP55 itself is involved in disease processes, serves as a drug target, or is integral to cellular pathways; its functional significance remains unclear[4][1][3][6].
- Other names
- RPL23AP55RPL23A_23_884
02
Biological functions
Other (Possible fine-tuning of gene expression through non-coding RNA effects; no established protein function)
03
Disease associations
Other (No direct evidence for disease involvement; ribosomal protein L23a pseudogene family may have indirect regulatory roles, e.g., as molecular sponges influencing microRNA activity)
04
Biomarkers
Potential association of expression with melanoma prognosis, as higher expression of related pseudogene (RPL23AP53) correlated with improved survival and altered immune cell infiltration profiles in melanoma patients
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 55 (RPL23AP55).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 55 (RPL23AP55).